Search

everythinglearnresearchcommunity

for

Search:↓

Storing hair follicles at -20°C keeps them good for up to 15 days, which may help with hair transplants.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

Telogen Effluvium causes more hair loss because hair moves to the resting phase too soon.

A woman had temporary hair loss after scalp surgery, which is a rare but self-healing condition that surgeons should recognize to avoid wrong treatment.

Iontophoresis with growth factors safely and effectively promotes hair regrowth without discomfort.

COVID-19 infection may cause hair loss.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

Indian dermatologists recommend treating common hair loss with a balanced diet, stress reduction, mild shampoos, and sometimes minoxidil and supplements.

Trichoscopy can help diagnose and monitor the progression of dissecting cellulitis.

The balance of thiol-disulfide in women with hair loss is affected but not damaged.

The document concludes that a new treatment for a type of hair loss called telogen effluvium was tested and shows promise.

Many people with hair loss had low iron and ferritin levels.

Both Ayurvedic treatments improved hair fall, with Shirodhara being especially effective.

The marine protein complex, Viviscal®, was found to effectively reduce hair loss and improve hair, skin, and nails quality in women.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

COVID-19 infection can significantly cause temporary hair loss.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Higher levels of ischemia-modified albumin in telogen effluvium patients may indicate oxidative stress.

Certain growth factors significantly affect hair loss in women with telogen effluvium.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Monocytes might be linked to hair loss after COVID-19.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

More atypical club hairs may indicate Telogen Effluvium.

Thyroid autoimmunity may be involved in some female hair loss, suggesting the need to test for thyroid antibodies in these patients.

Vitamin D levels are not correlated with chronic hair loss in Telogen Effluvium patients.

Low hemoglobin levels are significantly correlated with hair loss in women with Telogen Effluvium.

Women with a certain type of hair loss had lower levels of a hormone called prolactin compared to healthy women.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Hair care products with placental growth factor can improve hair thickness and density in postpartum hair loss.

Low vitamin D levels, not ferritin levels, were found in patients with hair loss condition telogen effluvium.